Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
BMJ Open
|
November 25, 2022
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study
Edson Tawanda Marambire, Denise Banze, Alfred Mfinanga, et al.
BMC Infectious Diseases
|
May 28, 2025
DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis
Nestani Tukvadze, Sehlomola Mashatole, Anne Jacobs, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 8, 2018
Seroepidemiological and molecular investigations of infections with Crimean-Congo haemorrhagic fever virus in Kazakhstan
Karlygash Abdiyeva, Nurkeldi Turebekov, Andrey Dmitrovsky, et al.
The European Respiratory Journal
|
February 5, 2021
Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg<sup>-1</sup> rifampicin
Lindsey H M Te Brake, Veronique de Jager, Kim Narunsky, et al.
The European Respiratory Journal
|
June 27, 2015
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania
Inge Kroidl, Petra Clowes, Klaus Reither, et al.
The Lancet. Infectious Diseases
|
April 23, 2026
Diagnostic and prognostic accuracy of the Mycobacterium tuberculosis host response 3-gene cartridge among tuberculosis household contacts in Mozambique, Tanzania, and Zimbabwe: a prospective, longitudinal, diagnostic and prognostic accuracy cohort study
Leyla Larsson, Ioana Diana Olaru, Anna-Lisa Behnke, et al.
Plos One
|
August 26, 2016
Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus
Sabine Dittrich, Birkneh Tilahun Tadesse, Francis Moussy, et al.
The Journal of Antimicrobial Chemotherapy
|
January 30, 2015
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich, Rodney Dawson, Jeannine du Bois, et al.
ERJ Open Research
|
July 22, 2025
Implications of reference equations for interpretation of spirometry in three African countries: a cross-sectional study
Denise Banze, Claire J Calderwood, Celina Nhamuave, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
BMJ Open
|
November 25, 2022
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study
Edson Tawanda Marambire, Denise Banze, Alfred Mfinanga, et al.
BMC Infectious Diseases
|
May 28, 2025
DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis
Nestani Tukvadze, Sehlomola Mashatole, Anne Jacobs, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 8, 2018
Seroepidemiological and molecular investigations of infections with Crimean-Congo haemorrhagic fever virus in Kazakhstan
Karlygash Abdiyeva, Nurkeldi Turebekov, Andrey Dmitrovsky, et al.
The European Respiratory Journal
|
February 5, 2021
Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg<sup>-1</sup> rifampicin
Lindsey H M Te Brake, Veronique de Jager, Kim Narunsky, et al.
The European Respiratory Journal
|
June 27, 2015
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania
Inge Kroidl, Petra Clowes, Klaus Reither, et al.
The Lancet. Infectious Diseases
|
April 23, 2026
Diagnostic and prognostic accuracy of the Mycobacterium tuberculosis host response 3-gene cartridge among tuberculosis household contacts in Mozambique, Tanzania, and Zimbabwe: a prospective, longitudinal, diagnostic and prognostic accuracy cohort study
Leyla Larsson, Ioana Diana Olaru, Anna-Lisa Behnke, et al.
Plos One
|
August 26, 2016
Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus
Sabine Dittrich, Birkneh Tilahun Tadesse, Francis Moussy, et al.
The Journal of Antimicrobial Chemotherapy
|
January 30, 2015
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich, Rodney Dawson, Jeannine du Bois, et al.
ERJ Open Research
|
July 22, 2025
Implications of reference equations for interpretation of spirometry in three African countries: a cross-sectional study
Denise Banze, Claire J Calderwood, Celina Nhamuave, et al.
Page
of 9